Revvity EBIT Margin 2010-2025 | RVTY

Revvity ebit margin for the quarter ending June 30, 2025 was 13.58%.

  • Revvity average ebit margin for 2024 was 10.96%, a 22.21% increase from 2023.
  • Revvity average ebit margin for 2023 was 14.09%, a 49.59% decline from 2022.
  • Revvity average ebit margin for 2022 was 27.95%, a 24.95% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Revvity EBIT Margin 2010-2025 | RVTY

  • Revvity average ebit margin for 2024 was 10.96%, a 22.21% increase from 2023.
  • Revvity average ebit margin for 2023 was 14.09%, a 49.59% decline from 2022.
  • Revvity average ebit margin for 2022 was 27.95%, a 24.95% decline from 2021.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$146.8B
CVS Health (CVS)$91.2B
Elevance Health (ELV)$69.8B
Cencora (COR)$56.3B
DiDi Global (DIDIY)$26.4B
Labcorp Holdings (LH)$23.2B
Natera (NTRA)$22.4B
BioMerieux (BMXMF)$17.4B
EUROFINS SCIENT (ERFSF)$14.9B
ICON (ICLR)$14.1B
Medpace Holdings (MEDP)$13.3B
CochLear (CHEOY)$13B
Solventum (SOLV)$12.6B
Viatris (VTRS)$12.1B
Caris Life Sciences,�Inc (CAI)$10.7B
Avantor (AVTR)$9B
Charles River Laboratories (CRL)$8B
Sonic Healthcare (SKHHY)$7.8B
HealthEquity (HQY)$7.6B
Bausch + Lomb (BLCO)$5.2B
Sotera Health (SHC)$4.7B
BrightSpring Health Services (BTSG)$4.2B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.7B
Alignment Healthcare (ALHC)$3.2B
Concentras Parent (CON)$3B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.4B
KindlyMD (NAKA)$2.4B
Premier (PINC)$2.2B